KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Share-based Compensation (2016 - 2025)

Sarepta Therapeutics has reported Share-based Compensation over the past 15 years, most recently at -$93.4 million for Q4 2025.

  • Quarterly results put Share-based Compensation at -$93.4 million for Q4 2025, down 232.4% from a year ago — trailing twelve months through Dec 2025 was -$57700.0 (down 100.03% YoY), and the annual figure for FY2025 was $14300.0, down 99.99%.
  • Share-based Compensation for Q4 2025 was -$93.4 million at Sarepta Therapeutics, down from $14.9 million in the prior quarter.
  • Over the last five years, Share-based Compensation for SRPT hit a ceiling of $102.9 million in Q2 2022 and a floor of -$93.4 million in Q4 2025.
  • Median Share-based Compensation over the past 5 years was $41.4 million (2023), compared with a mean of $37.3 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 255.18% in 2022 and later tumbled 232.4% in 2025.
  • Sarepta Therapeutics' Share-based Compensation stood at $29.8 million in 2021, then skyrocketed by 69.6% to $50.5 million in 2022, then fell by 9.3% to $45.8 million in 2023, then soared by 53.96% to $70.5 million in 2024, then tumbled by 232.4% to -$93.4 million in 2025.
  • The last three reported values for Share-based Compensation were -$93.4 million (Q4 2025), $14.9 million (Q3 2025), and $37.0 million (Q2 2025) per Business Quant data.